Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery

被引：0
|
作者：
Dai, Cong [1 ]
Huang, Yu-hong [1 ]
机构：
[1] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, 92 Beier Rd, Shenyang 110001, Liaoning, Peoples R China
来源：
DIGESTIVE DISEASES AND SCIENCES | 2022年 / 67卷 / 04期
关键词：
Crohn's disease; Anti-TNF agents; Elective surgery; Complications; POSTOPERATIVE COMPLICATIONS; THERAPY;
D O I：
10.1007/s10620-021-06976-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1421 / 1422
页数：2
相关论文
共 50 条
  • [41] Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients
    Strik, Anne S.
    Lowenberg, Mark
    Buskens, Christianne J.
    Gecse, Krisztina B.
    Ponsioen, Cyriel, I
    Bemelman, Willem A.
    D'Haens, Geert R.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (04) : 453 - 458
  • [42] Controversies in the management of anti-TNF therapy in patients with Crohn's disease: a Delphi consensus
    Gonzalez-Lama, Yago
    Ricart, Elena
    Carpio, Daniel
    Bastida, Guillermo
    Ceballos, Daniel
    Ginard, Daniel
    Marin-Jimenez, Ignacio
    Menchen, Luis
    Munoz, Fernando
    BMJ OPEN GASTROENTEROLOGY, 2024, 11 (01):
  • [43] The role of pharmacogenomics in the prediction of efficacy of anti-TNF therapy in patients with Crohn's disease
    Mascheretti, S
    Schreiber, S
    PHARMACOGENOMICS, 2004, 5 (05) : 479 - 486
  • [44] The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab
    Kassouri, Liza
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (10) : 1148 - 1155
  • [45] Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease
    Aggarwal, Divya
    Limdi, Jimmy K.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (01) : 13 - 19
  • [46] Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn’s Disease
    José María Paredes
    Nadia Moreno
    Patricia Latorre
    Tomás Ripollés
    María Jesús Martinez
    José Vizuete
    Eduardo Moreno-Osset
    Digestive Diseases and Sciences, 2019, 64 : 2600 - 2606
  • [47] Early Postoperative Anti-TNF Therapy Does Not Increase Complications Following Abdominal Surgery in Crohn's Disease
    Schad, Christine A.
    Haac, Bryce E.
    Cross, Raymond K.
    Syed, Ali
    Lonsako, Shumet
    Bafford, Andrea C.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (07) : 1959 - 1966
  • [48] Comparison of the Persistence of Anti-TNF Agents and Ustekinumab in Patients with Crohn's Disease: A Study Based on the Korean National Database
    Seo, Gi Hyeon
    Jung, Sung Hoon
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [49] Efficacy and predictor of anti-TNFα agents in patients with intestinal Behcet's disease
    Miyazaki, Haruka
    Watanabe, Daisuke
    Okamoto, Norihiro
    Tokunaga, Eri
    Ku, Yuna
    Takenaka, Haruka
    Hoshi, Namiko
    Ooi, Makoto
    Kodama, Yuzo
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [50] Anti-TNFα agents are the best choice in preventing postoperative Crohn's disease: A meta-analysis
    Eros, Adrienn
    Farkas, Nelli
    Hegyi, Peter
    Szabo, Aniko
    Balasko, Marta
    Veres, Gabor
    Czako, Laszlo
    Bajor, Judit
    Alizadeh, Hussain
    Rakonczay, Zoltan
    Miko, Alexandra
    Habon, Tamas
    Eross, Balint
    Berczi, Balint
    Sarlos, Patricia
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (08) : 1086 - 1095
12345